The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genomic grade: Feasibility in routine practice and influence on treatment decision in early breast cancer.
O. Metzger
No relevant relationships to disclose
A. Catteau
Employment or Leadership Position - Ipsogen
S. Michiels
No relevant relationships to disclose
M. E. Buyse
No relevant relationships to disclose
K. V. Saini
No relevant relationships to disclose
V. Fasolo
Employment or Leadership Position - Ipsogen
J. Canon
No relevant relationships to disclose
P. Delrée
No relevant relationships to disclose
M. Coibion
No relevant relationships to disclose
V. Jossa
No relevant relationships to disclose
J. Kains
No relevant relationships to disclose
D. Larsimont
No relevant relationships to disclose
V. Richard
No relevant relationships to disclose
D. Faverly
No relevant relationships to disclose
N. Cornez
No relevant relationships to disclose
P. Vuylsteke
No relevant relationships to disclose
B. Vanderschueren
No relevant relationships to disclose
H. P. Peyro Saint Paul
Employment or Leadership Position - Ipsogen
Stock Ownership - Ipsogen
M. J. Piccart-Gebhart
No relevant relationships to disclose
C. Sotiriou
No relevant relationships to disclose